Figure 1From: A genome-wide association study of chemotherapy-induced alopecia in breast cancer patientsThe proportions of patients by alopecia grade in each weighted genomic risk score. The proportions of patients who developed no adverse reaction (G0), grade 1 alopecia, or grade 2 alopecia in each of the weighted genomic risk score (wGRS) groups. The number in parentheses indicates the number of samples in each group. (A) paclitaxel monotherapy, (B) docetaxel monotherapy.Back to article page